| San Diego Biotechnology Network

Halozyme Announces First Clinical Dosing In argenx’s Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Technology

July 17, 2019 sandiegobiotech Comments Off

SAN DIEGO, July 17, 2019 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that argenx has dosed the first subject in a phase 1 clinical trial … […]

Trefoil Therapeutics Raises $28M and Eyes the Clinic for Cornea Drug

July 16, 2019 sandiegobiotech Comments Off

Trefoil Therapeutics, which is developing treatments for diseases that affect the cornea, the outermost layer of the eye, has raised $28 million to move its lead drug candidate into human testing. The company is developing an engineered form of fibrobl… […]

With Illumina and Google ties, San Diego startup Cradle Genomics gets $17M

July 16, 2019 sandiegobiotech Comments Off

Prestigious investors from Section 32 and Illumina Ventures have backed Cradle Genomics, a startup developing prenatal tests […]

NSF Awards $10 Million to SDSC to Deploy ‘Expanse’ Supercomputer

July 16, 2019 sandiegobiotech Comments Off

[…]

TMRW Robotic Process Automation Platform Goes Live at San Diego Fertility Center, Vios Fertility Institute – Chicago and Reproductive Medicine Associates of New York

July 16, 2019 sandiegobiotech Comments Off

Multi-Site Study to Track Improvements to Safety and Results Achieved through Process Automation for the Preservation of Embryos and Other Fertility Cells

NEW YORK and CHICAGO and SAN DIEGO, July 16, 2019 /PRNewswire/ — TMRW, the creator of the firs… […]

With $17M, Illumina Ties, Prenatal Tests Firm Cradle Genomics Debuts

July 16, 2019 sandiegobiotech Comments Off

Another company headed by former Illumina executives has launched, fueled with a $17 million Series A round from investors including a local venture capital firm. The new firm, Cradle Genomics, is seeking to commercialize improved non-invasive prenatal… […]

San Diego ophthalmic biotech upstart raises $28M on alternative to corneal transplant

July 16, 2019 sandiegobiotech Comments Off

Texas VC Bios Partners has found a new early-stage play to love out of San Diego, leading a $28 million Series A to help Trefoil Therapeutics make the leap to the clinic.
Stella Robertson Bios Partners
Stella Robertson, who headed R&D at Novartis’ … […]

Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer

July 16, 2019 sandiegobiotech Comments Off

SAN DIEGO, July 16, 2019 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, toda… […]

Illumina Expands Genomics Accelerator to Cambridge, UK

July 15, 2019 sandiegobiotech Comments Off

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focuse… […]

These 3 out-of-town VCs invested millions in San Diego startups this quarter

July 15, 2019 sandiegobiotech Comments Off

Three venture capital firms were the most active in San Diego during the second quarter of 2019 […]